What tetanus immune globulin (TIG) dose should be administered for wound prophylaxis in a patient with uncertain or incomplete tetanus immunization (fewer than three prior tetanus toxoid doses or no booster in the past five years) for routine clean or mildly contaminated wounds versus heavily contaminated, deep, or necrotic wounds?

Tetanus Immunoglobulin Dosing for Wound Prophylaxis

The standard prophylactic dose of tetanus immune globulin (TIG) is 250 units intramuscularly, administered at a separate anatomic site from tetanus toxoid using separate syringes, for patients with fewer than three documented tetanus toxoid doses or unknown vaccination history. 1, 2, 3

Dosing Algorithm Based on Vaccination History and Wound Type

For Patients with ≥3 Prior Tetanus Doses (Complete Primary Series)

Clean, minor wounds:

• If last dose was <10 years ago: No vaccine or TIG needed 2
• If last dose was ≥10 years ago: Give tetanus toxoid (Tdap preferred) WITHOUT TIG 2

Contaminated/tetanus-prone wounds (puncture wounds, deep wounds, wounds with dirt/soil/feces, necrotic tissue):

• If last dose was <5 years ago: No vaccine or TIG needed 2
• If last dose was ≥5 years ago: Give tetanus toxoid (Tdap preferred) WITHOUT TIG 1, 2

For Patients with <3 Prior Doses or Unknown/Uncertain History

Any wound type (clean or contaminated):

• Give BOTH tetanus toxoid-containing vaccine (Tdap preferred) AND TIG 250 units IM at separate anatomic sites using separate syringes 1, 2, 3
• Treat unknown or uncertain vaccination history as zero prior doses 2

Critical Dosing Details

TIG dose is universal and non-weight-based:

• 250 units IM for both adults and children 2
• This single dose provides immediate passive immunity for approximately 4 weeks 4

Administration technique:

• TIG and tetanus toxoid MUST be given at different anatomical sites (e.g., opposite deltoids or deltoid and thigh) using separate syringes to prevent interference with active immunization 1, 2, 3
• Human TIG is strongly preferred over equine antitoxin because it provides longer protection (4 weeks vs 7-10 days) and causes fewer adverse reactions 2, 4

Special Population Considerations

Severely immunocompromised patients (HIV infection, severe immunodeficiency, recent rituximab therapy):

• Require TIG 250 units IM for contaminated wounds REGARDLESS of documented vaccination history, because they may not mount adequate antibody responses to vaccine alone 2, 3, 5

Pregnant women:

• If TIG is indicated, give the standard 250 units IM dose 2
• Use Tdap for the tetanus toxoid component regardless of prior Tdap history 2

Elderly patients (≥60 years):

• Prioritize for TIG if supplies are limited, as 49-66% lack protective antibody levels 2, 5

Immigrants from regions outside North America/Europe:

• Prioritize for TIG if supplies are limited, as they are less likely to have adequate vaccination history 2

Timing of Administration

TIG should be given as soon as possible once the need is identified:

• No established time limit renders it ineffective for wound prophylaxis 3
• Do NOT withhold TIG simply because several days have elapsed since injury 3
• The guideline emphasizes "as soon as possible" but establishes no absolute cutoff 3

Immunologic Rationale

Why TIG is necessary for incomplete vaccination:

• Tetanus toxoid does not provide immediate protection—it takes several days to weeks to generate active immunity 2
• Even in previously vaccinated individuals who receive a booster, there is NO detectable antitoxin response within the first 4 days 6
• TIG provides immediate passive protection during this vulnerable window 6, 4

Why TIG is NOT needed for complete vaccination:

• Persons with at least two prior doses develop antitoxin antibodies rapidly after a booster (within days, though not within 4 days), and their baseline antibody levels from prior vaccination provide protection 6, 4
• Complete primary vaccination provides nearly 100% protection and long-lasting immunity for at least 10 years 2

TIG does not interfere with active immunization:

• Multiple studies demonstrate that simultaneous administration of TIG (even in therapeutic doses up to 45,000 IU) and tetanus toxoid does not impair the antibody response to complete active immunization 7, 8, 9
• The rise in antibody titer after the third dose of toxoid is of the same magnitude as in patients receiving only active immunization 8

Common Pitfalls to Avoid

Do not confuse the 10-year routine booster interval with the 5-year interval for contaminated wounds:

• This is the most common error in tetanus prophylaxis 2
• Contaminated wounds require a booster if ≥5 years since last dose, even with complete vaccination history 2

Do not give TIG to patients with ≥3 documented doses:

• TIG is unnecessary and wasteful for patients with complete primary vaccination, regardless of wound type, unless they are severely immunocompromised 2, 5

Do not administer TIG and tetanus toxoid at the same anatomic site:

• Always use separate syringes and separate sites to prevent interference 1, 2, 3

Do not forget to complete the primary series:

• Patients receiving TIG must complete a 3-dose primary tetanus vaccination series for long-term protection 2
• Second dose at ≥4 weeks, third dose at 6-12 months after the second dose 2